Shares of Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report) traded up 7.8% during trading on Wednesday . The stock traded as high as $0.20 and last traded at $0.19. 19,100 shares changed hands during trading, a decline of 88% from the average session volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Price Performance
The stock has a 50 day moving average price of $0.19 and a two-hundred day moving average price of $0.19. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.04.
About Vyant Bio
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
See Also
- Five stocks we like better than Vyant Bio
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What Is WallStreetBets and What Stocks Are They Targeting?
- How Do Stock Buybacks Affect Shareholders?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
